Brian Lindman, Sammy Elmariah, and David Wood explain how echocardiogram alerts are assisting in the management and evaluation of aortic stenosis patients.

Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes. 

Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.

Michael Mack speaks to Allan Schwartz, a principal investigator of the EARLY TAVR trial, who explains how it informs patient management.

Bernard Prendergast and Philippe Généreux detail the EARLY TAVR trial design and outcomes.

Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early diagnosis of valvular heart disease.

Juan Granada and Brian Lindman share insights on tools and data that can be used to achieve earlier diagnosis and intervention in valvular heart disease.

Sammy Elmariah and David Playford discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis. 

Martha Gulati and Kathyn Berlacher talk about tangible ways to improve women's cardiovascular care, including nontraditional, patient-centered solutions.

Clyde Yancy, Suzanne Baron, and Bruce Rutkin discuss ways to address the undertreatment of CVD in women at the patient, provider, structural, and societal levels.